Cytokine Induction During Cardiac Surgery: Analysis of TNF‐α Expression Pre‐and Postcardiopulmonary Bypass

Journal of Cardiac Surgery

Volumn 10, Issue , 1995, Pages 418-422

  Hattler, Brack G ^a   Zeevi, Adriana ^a   Oddis, Carmine V ^a   Finkel, Mitchell S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL STRESS; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEART; HUMAN; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; RNA, MESSENGER; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0029119246     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1995.tb00671.x     Document Type: Article

References (29)

1. The biology of interleukin‐1 and comparison to tumor necrosis factor
2. Increased secretion of tumor necrosis factor‐a and interferon‐a by mononuclear leukocytes in patients with ischemic heart disease
3. Cytokines and lung
4. Negative inotropic effects of cytokines on the heart mediated by NO
5. Interleukin‐6, a myocardial depressant factor and its possible role in myocardial reperfusion injury in man
6. lnterleukin‐6 (IL‐6) as a mediator of stunned myocardium
7. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
8. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation
9. Inhibition of tumor induced lymphocyte blastogenesis by a factor(s) associated with peripheral leukocytes
10. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
11. Message amplification phenotyping (MAPPing): A technique to simultaneously measure multiple mRNAs from small numbers of cells
12. Why cardiopulmonary bypass makes patients sick: Strategies to control the blood‐surface interface
13. Release of vasoactive substances during cardiopulmonary bypass
14. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass
15. Interleukin‐2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock
16. Interleukin‐1 and tumor necrosis factor inhibit cardiac myocyte B‐adrenergic responsiveness
17. Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusion
18. Two distinct cytokines, interleukin‐1 and tumor necrosis factor, each independently induces biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells
19. Assessment of the immediate effects of cardiopulmonary bypass on ventricular performance using real time pressure‐area relations
20. Serum interleukin‐6 levels become elevated in acute myocardial infarction
21. Detection of circulating tumor necrosis factor after endotoxin administration
22. Do cytokine‐inducing substances penetrate through dialysis membranes and stimulate monocytes
23. Gene expression of interleukin‐1 beta during hemodialysis
24. C3a induces production and release of interleukin‐1 by cultured human monocytes
25. Recombinant C5a stimulates transcription rather than translation of IL‐1 and TNF; priming of mononuclear cells with recombinant C5a enhances cytokine synthesis induced by LPS, IL‐1 or PMA
26. Cuprammonium membranes stimulate interleukin release and arachidonic acid metabolites in the absence of complement